USHG Acquisition Corp.

Condensed Statement of Cash Flows

~~Condensed Statements of Changes in Stockholders’ Equity~~

~~Three and Six months ended June~~Nine Months Ended September 30, 2021

(Unaudited)

Common Stock

Additional Paid-
In Capital

Retained Earnings

Total


Class A

Class B


Shares

Amount

Shares

Amount

(Accumulated
Deficit)

Stockholders’
Equity

Balance as of January 1, 2021


—

$
—

6,934,500


$
693


$
23,427

$
(10,000
)

$
14,120

Sale of Units in initial public offering, less fair value of public warrants
   28,750,000 2,875 —      —      274,367,958 —   274,370,833
Offering costs
   —   —   —      —      (15,845,672 ) —   (15,845,672 )
Excess of cash received over fair value of warrants sold to Sponsor
   —   —   —      —      146,667 —   146,667
Change in Class A common stock subject to possible redemption
   (25,745,225 ) (2,575 ) —      —      (257,449,675 ) —   (257,452,250 )
Net income
   —   —   —      —      —   3,766,309 3,766,309






Balance as of March 31, 2021(unaudited)


3,004,775

$
300

6,934,500


$
693


$
1,242,705

$
3,756,309

$
5,000,007







Offering costs related to Initial Public Offering    —   —   —      —      (42,160 ) —   (42,160 )
Change in Class A common stock subject to possible redemption
   125,675 13 —      —      1,256,737 —   1,256,750
Net
loss
   —   —   —      —      —   (1,214,595 ) (1,214,595 )






Balance as of June 30, 2021 (unaudited)


3,130,450

$
313

6,934,500

$
693


$
2,457,282

$
2,541,714

$
5,000,002


	For the Nine Months ended September 30, 2021
Cash Flows from Operating Activities
Net income	$	4,194,795
Adjustments to reconcile net income to net cash used in operating activities
Change in fair value of warrant liabilities		(5,642,686	)
Offering costs allocated to derivative warrant liabilities		757,984
Interest earned on marketable securities in Trust Account		(10,052	)
Changes in operating assets and liabilities
Prepaid expenses		(469,504	)
Other assets		(187,387	)
Accounts payable		19,650
Franchise tax payable		150,000
Accrued expenses		13,995

Net cash used by operating activities		(1,173,205	)

Cash Flows from Investing Activities
Cash deposited in Trust Account		(287,500,000	)

Net cash used in investing activities		(287,500,000	)

Cash Flows from Financing Activities
Proceeds from issuance of Class A common stock and warrants		289,500,000
Proceeds from note payable and advances from related party		336,017
Repayment of note payable and advances from related party		(336,017	)
Payment of offering costs		(219,607	)

Net cash provided by financing activities		289,280,393

Net increase in cash		607,188
Cash—beginning of period		24,120

Cash—end of period	$	631,308

Supplemental disclosure of noncash investing and financing activities:
Deferred legal fees	$	613,708

Deferred underwriting compensation	$	15,812,500

Deferred offering costs included in accrued expenses	$	255,000

The accompanying notes are an integral part of these

condensed

financial statements.

Table of Contents

~~USHG Acquisition Corp.~~

~~Condensed Statement of Cash Flows~~

~~Six Months Ended June 30, 2021~~

~~(Unaudited)~~

For the six months
ended June 30, 2021

Cash Flows from Operating Activities

Net income
   $ 2,551,714
Adjustments to reconcile net income to net cash used in operating activities

Amortization of prepaid insurance
   174,769
Change in fair value of warrant liabilities
   (3,715,534 )
Offering costs allocated to derivative warrant liabilities
   757,984
Interest earned on
marketable securities
in Trust Account
   (5,711 )
Formation and operating expenses funded by Sponsor
   1,567
Changes in operating assets and liabilities

Prepaid expenses
   (541,426 )
Other assets
   (414,486 )
Accounts payable
   31,231
Franchise tax payable
   100,000
Accrued expenses
   6,050


Net cash used by operating activities
   (1,053,842 )


Cash Flows from Investing Activities

Cash deposited in Trust Account
   (287,500,000 )


Net cash used in investing activities
   (287,500,000 )


Cash Flows from Financing Activities

Proceeds from issuance of Class A common stock and warrants
   289,500,000
Proceeds from note payable and advances from related party
   334,000
Repayment of note payable and advances from related party

(334,000
)
Payment of offering costs
   (199,608 )


Net cash provided by financing activities
   289,300,392


Net increase in cash
   746,550
Cash—beginning of period
   24,120


Cash—end of period
   $ 770,670


Supplemental disclosure of noncash investing and financing activities:

Change in value of Class A
common stock
subject to possible redemption
   $ 1,272,990


Warrant liabilities in connection with initial public offering and private placement
   $ 14,982,500


Deferred offering costs included in accounts payable
   $ 20,000




Deferred legal fees
   $ 613,708


Deferred underwriting compensation
   $ 15,812,500

~~The accompanying notes are an integral part of these~~

~~condensed~~

~~financial statements.~~

~~Table of Contents~~

USHG ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS ~~JUNE~~SEPTEMBER 30, 2021

(Unaudited)

Note 1—Description of Organization and Business Operations

USHG Acquisition Corp. (the “Company”) is a blank check company formed as a Delaware corporation on December 4, 2020. The Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities that the Company has not yet identified (“Business Combination”).

As of ~~June~~September 30, 2021, the Company had not yet commenced operations. All activity through ~~June~~September 30, 2021 relates to the Company’s formation and its Initial Public Offering (the “Initial Public Offering”), which is described below. The Company has selected December 31 as its fiscal year end.

On March 1, 2021, the Company consummated the Initial Public Offering of 28,750,000 units (the “Units” and with respect to the Class A common stock included in the Units being offered, the “Public Shares”), including 3,750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover over-allotments. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $287,500,000, which is described in Note 3.4.

Simultaneously with the closing of the Initial Public Offering, the Company completed the private sale of 1,333,333 warrants (the “Private Placement Warrants”) at a purchase price of $1.50 per Private Placement Warrant (the “Private Placement”), to USHG Investments, LLC (the “Sponsor”), generating gross proceeds to the Company of $2,000,000, which is described in Note 3.4.

Offering costs consist of legal, accounting, and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering and were charged to

stockholders’

equity upon completion of the Initial Public Offering and during the current quarter ended ~~June~~September 30, 2021.

Following the closing of the Initial Public Offering on March 1, 2021, an amount of $287,500,000 ($10 per Unit) of the proceeds from the Initial Public Offering, including $15,812,500 of the underwriters’ deferred discount was placed in a trust account located in the United States at J.P. Morgan Chase Bank, N.A. maintained by American Stock Transfer & Trust Company, LLC, acting as trustee (the “Trust Account”). Except with respect to interest earned on the funds in the Trust Account that may be released to the Company to pay its franchise and income taxes and expenses relating to the administration of the Trust Account, the proceeds from the Initial Public Offering held in the Trust Account will not be released until the earliest of (a) the completion of the Company’s initial Business Combination, (b) the redemption of any Public Shares of the Company properly tendered in connection with a

stockholder

vote to amend the Company’s Second Amended and Restated Certificate of Incorporation, which was adopted upon the consummation of the Initial Public Offering (the “Amended and Restated Certificate of Incorporation”) (i) to modify the substance or timing of its obligation to redeem 100% of the Public Shares if the Company does not complete its initial Business Combination within 24 months from the closing of the Initial Public Offering or (ii) with respect to any other provisions relating to stockholders’ rights or

pre-initial

Business Combination activity, and (c) the redemption of all of the Public Shares if it is unable to complete its Business Combination within 24 months from the closing of the Initial Public Offering, subject to applicable law.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s initial Business Combination must be with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Upon the closing of the Initial Public Offering, management has agreed that an amount equal to at least $10.00 per Unit sold in the Initial Public Offering are held in the Trust Account with American Stock Transfer & Trust Company, LLC acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

Table of Contents

The Company will provide its holders of the Public Shares (the “Public Stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The

per-share

amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5)6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem Public Shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the transaction. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 6)7) prior to the Initial Public Offering (the “Initial Stockholders”) have agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.

Notwithstanding the foregoing, the Amended and Restated Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A common stock sold in the Initial Public Offering, without the prior consent of the Company.

The Sponsor, executive officers and directors will have agreed not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Stockholders with the opportunity to redeem their Class A common stock in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.

In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes (less up to $100,000 of interest to pay dissolution expenses).

The Initial Stockholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders should acquire Public Shares after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public

~~Table of Contents~~

Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to

Table of Contents

waive their rights to their deferred underwriting commission (see Note 5)6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period, and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to ~~any~~an

claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Risks and Uncertainties

Management continues to evaluate the impact of the

COVID-19

pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statement. The financial statement ~~does~~

do not include any adjustments that might result from the outcome of this uncertainty.

Note 2—Restatement of Previously Issued Financial Statements

In connection with the preparation of th

Company’s financial statements as of September 30, 2021, management determined it should restate its previously reported financial statements. The Company determined, at the closing of the Company’s Initial Public Offering, including the exercise of the underwriters’ overallotment option, it had improperly valued its Class A common stock subject to possible redemption. The Company previously classified as temporary equity the Class A common stock subject to possible redemption to be equal to the redemption value of

$10.00

per Class A common stock, while also taking into consideration that a redemption cannot result in net tangible assets being less than

$5,000,001.

Management determined that the Class A common stock issued during the Initial Public Offering, including the shares purchased in the exercise of the underwriters’ overallotment option, can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management concluded that the temporary equity should include all Class A common stock subject to possible redemption. This resulted in a restatement to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock.

In connection with the change in presentation for the Class A common stock subject to redemption, the Company also restated its earnings per share calculation to allocate net income pro rata between the Class A common stock and Class B common stock. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of common stock share pro rata in the income of the Company.

This reclassification adjustment resulted in no change in the Company’s total assets, liabilities, or operating results. The impact of the restatement on the Company’s financial statements is reflected in the following table.

	As of June 30, 2021
	As Previously Reported			Adjustment			As Restated
Balance Sheet
Common stock subject to possible redemption	$	256,195,500		$	31,304,500		$	287,500,000
Stockholders’ equity (deficit)
Class A common stock - $0.0001 par value		313			(313	)		—
Class B common stock - $0.0001 par value		693			—			693
Additional paid-in capital		2,457,282			(2,457,282	)		—
Accumulated deficit		2,541,714			(28,846,903	)		(26,305,189	)

Total Stockholders’ equity (deficit)	$	5,000,002		$	(31,304,498	)	$	(26,304,496	)


	Three Months Ended June 30, 2021
	As Previously Reported			Adjustment			As Restated
Statement of Operations
Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted		28,750,000			—			28,750,000
Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted		6,934,500			—			6,934,500
Basic and diluted net income (loss) per share, Class A common stock subject to possible redemption	$	0.00		$	(0.03	)	$	(0.03	)
Basic and diluted net income (loss) per share, Class B non-redeemable common stock	$	(0.18	)	$	0.15		$	(0.03	)

	Six Months Ended June 30, 2021
	As Previously Reported			Adjustment			As Restated
Statement of Operations
Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted		28,750,000			(9,371,547	)		19,378,453
Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted		6,934,500			—			6,934,500
Basic and diluted net income (loss) per share, Class A common stock subject to possible redemption	$	0.00		$	0.10		$	0.10
Basic and diluted net income (loss) per share, Class B non-redeemable common stock	$	0.37		$	(0.27	)	$	0.10


	As of March 31, 2021
	As Previously Reported		Adjustment			As Restated
Balance Sheet
Common stock subject to possible redemption	$	257,452,250	$	30,047,750		$	287,500,000
Stockholders’ equity (deficit)
Class A common stock - $0.0001 par value		300		(300	)		—
Class B common stock - $0.0001 par value		693		—			693
Additional paid-in capital		1,242,705		(1,242,705	)		—
Accumulated deficit		3,756,309		(28,804,744	)		(25,048,435	)

Total Stockholders’ equity (deficit)	$	5,000,007	$	(30,047,749	)	$	(25,047,742	)

	Three Months Ended March 31, 2021
	As Previously Reported			Adjustment			As Restated
Statement of Operations
Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted		25,500,411			(15,597,633	)		9,902,778
Weighted average shares outstanding of Class B non-redeemable common stock, basic and diluted		6,934,500			—			6,934,500
Basic and diluted net income (loss) per share, Class A common stock subject to possible redemption	$	0.00		$	0.22		$	0.22
Basic and diluted net income (loss) per share, Class B non-redeemable common stock	$	0.54		$	(0.32	)	$	0.22

	As of March 1, 2021
	As Previously Reported			Adjustment			As Restated
Balance Sheet
Common stock subject to possible redemption	$	254,922,510		$	32,577,490		$	287,500,000
Stockholders’ equity (deficit)
Class A common stock - $0.0001 par value		326			(326	)		—
Class B common stock - $0.0001 par value		693			—			693
Additional paid-in capital		5,772,419			(5,772,419	)		—
Accumulated deficit		(773,434	)		(28,804,744	)		(29,578,178	)

Total Stockholders’ equity (deficit)	$	5,000,004		$	(34,577,489	)	$	(29,577,485	)

Table of Contents

Note 3—Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and Article 8 of Regulation

S-X.

Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the three and ~~six~~nine months ended ~~June~~September 30, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021.

The accompanying unaudited condensed financial statements should be read in conjunction with Company’s prospectus for its Initial Public Offering as filed with the SEC on February 25, 2021 and the Form

10-Q

for the three and six months ended ~~March 31,~~June 30, 2021 as filed with the SEC on ~~May 24,~~August 16, 2021.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-

emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can

The Company’s provision for income taxes and deferred tax assets were deemed to be de minimis as of ~~June~~September 30, 2021 and December 31, 2020.

Recent Accounting Pronouncements

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)

2020-06,

Debt — Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic

815-40) (“

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all convertible instruments. ASU

2020-06

is effective January 1, ~~2022~~202

and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. Management is currently evaluating the new guidance but does not expect the adoption ofo

this guidance to have a material impact on the Company’s financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Note 3—4—Initial Public Offering and Private Placement

Pursuant to the Initial Public Offering, the Company sold 28,750,000 Units at a purchase price of $10.00 per Unit, including 3,750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover over-allotments. Each Unit consists of one share of Class A common stock

and one-third of

one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase 1 share of Class A common stock at an exercise price of $11.50 per share, subject to adjustment (see Note 6)7).

Simultaneously with the closing of the Initial Public Offering, the Company completed a sale of 1,333,333 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant (the “Private Placements”), to the Sponsor, generating gross proceeds to the Company of $2,000,000. The Private Placement Warrants are identical to the warrants sold as part of the Units in the Initial Public Offering, except that the Sponsor has agreed not to transfer, assign, or sell any of the Private Placement Warrants (except to certain permitted transferees) until 30 days after the completion of the Company’s initial Business Combination. So long as the Private Placement Warrants are held by the Sponsor, the Private Placement Warrants will not be redeemable for cash by the Company and will be exercisable on a cashless basis.

Note 4—5—Related Party Transactions

Founder Shares

On December 29, 2020, the Sponsor paid an aggregate of $24,120 in exchange for the issuance of 6,934,500 shares of Class B common stock (the “Founder Shares”). In January 2021, the Sponsor made a charitable contribution of 115,000

of the Founder Shares to Share Our Strength, a 501(c)(3) nonprofit organization. On March 1, 2021, the underwriters exercised the over-allotment option in ~~full; thus the common stock are no longer subject~~full to ~~forfeiture.~~purchase 904,500 founder shares.

The Initial Stockholders have agreed not to transfer, assign or sell any of the Founder Shares until the earlier to occur of (1) one year after the completion of the initial Business Combination and (2) subsequent to the Business Combination, (x) if the closing price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends and similar transactions) for any 20 trading days within

any 30-trading day

period commencing at least 150 days after the Business Combination (provided that

the 30-trading day

period must be completed prior to any such transfer, assignment or sale), or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s Public Stockholders having the right to exchange their shares of Class A common stock for cash, securities or other property.

Related Party Loans

In order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds that we refer to as ~~may be required~~ Working Capital Loans. If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside

~~Table of Contents~~

the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside

Table of Contents

the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2.0 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of ~~June~~September 30, 2021, the Company had 0 borrowings under the Working Capital Loans.

Administrative Services Agreement

The Company has entered into an Administrative Services Agreement pursuant to which the Company will pay an affiliate of the Sponsor a total of $10,000 per month, until the earlier of the completion of the initial Business Combination and the liquidation of the trust assets, for office space, secretarial and administrative services. Upon completion of the initial Business Combination or liquidation, the Company will cease paying these monthly fees. For the three and ~~six~~nine months ended ~~June~~September 30, 2021, the Company has paid ~~$20,000~~$30,000 and ~~$50,000~~$80,000 for the services provided through the Administrative Services Agreement, $10,000 of which ~~are~~was recorded as a prepaid expense on the unaudited condensed balance sheet as of ~~June~~September 30, 2021.

Note 5—6—Commitments and Contingencies

Registration and Stockholder Rights

The holders of the Founder Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans (and any Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement entered into prior to the closing of the Initial Public Offering. The holders of these securities may at any time, and from time to time, request in writing that the Company register the resale of any or all of these securities on

Form S-3 or

any similar short form registration statement that may be available at such time; provided, however, that the Company shall not be obligated to ~~effect~~fulfill such request through an underwritten offering. In addition, the holders have certain ~~“piggy-back”~~��piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters an option to cover over-allotments and for market stabilization purposes. The over-allotment option entitled the underwriters to purchase on a pro rata basis up to 3,750,000 additional units at the Initial Public Offering price, less the underwriting discounts and commissions. The underwriters exercised the over-allotment option in full and purchased an additional 3,750,000 units at closing of the Initial Public Offering. As of ~~June~~September 30, 2021, the Company has incurred $15,812,500 in deferred underwriting costs, ~~$757,984~~all of which ~~were recognized in other expenses with the reminder~~was recorded inas a reduction to

temporary stockholders’ equity.

Deferred legal fees

The Company obtained legal advisory services in connection with the Initial Public Offering and agreed to pay their fees upon the consummation of the initial Business Combination. As of ~~June~~September 30, 2021, the Company recorded approximately ~~$613,000~~$613,708 in deferred legal fees in connection with such agreements in the accompanying balance sheet.

Note 6—7—Warrant Liability

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60

day after the closing of the initial Business

~~Table of Contents~~

Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the

Company will have failed to maintain an

Table of Contents

effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the shares of Class A common stock are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to ~~the~~th

Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described under “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described under the caption “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be

non-redeemable

so long as they are held by the initial purchaser or such purchaser’s permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Stockholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Redemption of warrants when the price per share of Class

A common stock equals or exceeds $18.00:

Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):

in whole and not in part;

at a price of $0.01 per warrant;

upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

if, and only if, the last reported sale price (the “closing price”) of shares of Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available throughout the

30-day

redemption period.

Redemption of warrants when the price per share of Class

A common stock equals or exceeds $10.00:

Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock to be determined by reference to an agreed table based on the redemption date and the “fair market value” of shares of Class A common stock;

Table of Contents

if, and only if, the last reported sale price of Class A common stock equals or exceeds $10.00 per share (as adjusted) on the trading day prior to the date on which of redemption is sent to the warrant holders.

The “fair market value” shall mean the volume-weighted average price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Note 8—Stockholders’ Equity

(

Deficit

)

~~Note 7—Stockholders’ Equity~~

Preferred Stock

— The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At September 30, 2021 and December 31, 2020, there were 0 shares of preferred stock issued or outstanding.

Class

A Common Stock

— The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. At ~~June~~both September 30, 2021 and December 31,2020, there were ~~3,130,450 shares and~~ 0 shares of Class A common stock issued and outstanding, ~~respectively,~~ excluding ~~25,619,550 shares and 0~~28,750,000 shares of common stock subject to possible ~~redemption, respectively.~~redemption.

Class

B Common Stoc

k — The Company is authorized to issue 20,000,000 shares of Class B common stock with a par value of $0.0001 per share. On December 29, 2020, 6,934,500 shares of Class B common stock were issued. In January 2021, the Sponsor made a charitable contribution of 115,000 Sponsor Founder Shares to Share Our Strength, a 501 (c)(3) nonprofit organization. Prior to or in connection with the Company’s initial Business Combination, the Company may issue up to an additional 253,000 shares of Class B common stock (such shares, the “Discretionary Allocation Shares”) to persons who assist the Company, or agree to assist the Company, in varying capacities, which may include, without limitation, identifying a Business Combination partner, consummating the initial Business Combination or post-Business Combination advisory or similar services.

Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Except as described below, holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the stockholders except as required by law.

The shares of Class B common stock will automatically convert into shares of Class A common stock at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Founder Shares, including the Discretionary Allocation Shares, will equal, in the aggregate, on

an as-converted basis,

20% of the sum of (i) the total number of all shares of common stock that were issued and outstanding upon completion of the Initial Public Offering, plus (ii) the Discretionary Allocation Shares and plus (iii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of working capital loans.

~~Preferred Stock~~

— The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share. At June 30, 2021 and December 31, 2020, there were 0shares of preferred stock issued or outstanding.

Note ~~8 —~~ 9—Fair Value Measurements

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of ~~June~~September 30, 2021 and December 31, 2020, indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable, such as quoted prices, interest rates and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.

The Company’s investments held in the Trust Account is investments in money market funds that invest in U.S. government securities. Gains and losses resulting from the change in fair value of these securities is included in net gain from investments held in Trust Account in the accompanying unaudited condensed statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market

information.

Table of Contents

The following table presents the estimated fair values of investments held in the Trust Account as of ~~June~~September 30, 2021:


Held-To-Maturity	Level	Fair Value		Level		Fair Value
U.S. Treasury Marketable securities held in Trust Account—U.S. Treasury Securities Money Market Fund	1	$	287,505,711		1	$	287,510,052

The Warrants are accounted for as liabilities pursuant to ASC

815-40

and are measured at fair value as of each reporting period. Changes in the fair value of the Warrants are recorded in the statement of operations each period.

The following table presents the fair value hierarchy for liabilities measured at fair value on a recurring basis as of ~~June~~September 30, 2021:


	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Warrant liabilities:
Public Warrants	$	9,870,833	$	0	$	0	$	0	$	8,193,750	$	0	$	0	$	8,193,750
Private Placement Warrants		0		0		1,396,133		1,396,133		0		0		1,146,064		1,146,064

Total warrant liabilities	$	9,870,000	$	0	$	1,396,133	$	11,266,966	$	8,193,750	$	0	$	1,146,064	$	9,339,814

The Private Placement Warrants ~~were~~wer

valued using a Black Scholes Model, which is considered to be a Level 3 fair value measurement. The primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the volatility rate. The volatility applied was ~~16%~~14.25% based on implied volatilities from selected publicly traded warrants.

Beginning on April 19, 2021, the Public Warrants began trading under the ticker HUGSW. After this date, Public Warrant values per share were based on the observed trading prices of the Public Warrants. Accordingly, as of June 30, 2021, the observable input qualifies the liability for treatment as a Level 1 liability. As of March 31, 2021, the Company valued the Public Warrants ~~using Monte Carlo simulation model~~at their public trading price and classified the Public Warrants as Level ~~3. Except for the Public Warrants being classified as Level 1 liability as of June 30, 2021, there~~1. There were ~~0transfer in or out of Level 3 classification~~no transfers between levels during the quarter ended ~~June~~September 30, 2021.

~~Table of Contents~~

The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:


	As of June 30, 2021			As of September 30, 2021
Exercise price	$	11.50		$	11.50
IPO price	$	10.00		$	10.00
Implied stock price range (or underlying asset price)	$	9.70
Underlying asset price (per share)				$	9.71
Volatility		16	%		14.25	%
Term		5.83
Time to Maturity (Years)					5.71
Risk-free rate		1.01	%		1.10	%
Dividend yield		0.0	%		0.00	%

The following table presents a summary of the changes in the fair value of the Warrants:

							Public Warrant Liability			Private Warrant Liability			Total
	Public			Private Placement
	Warrant Liability			Warrant Liability
	Warrant Liability			Warrant Liability
Fair value, March 1, 2021	$	13,129,167		$	1,853,333
Recognized gain on change in fair value		(4,025,000	)		(560,000	)
Fair value, March 01, 2021							$	13,129,167		$	1,853,333		$	14,982,500
Recognized loss on change in fair value								(4,025,000	)		(560,000	)		(4,585,000	)

Fair value, March 31, 2021	$	9,104,167		$	1,293,333		$	9,104,167		$	1,293,333		$	10,397,500

Recognized loss on change in fair value		766,666			102,800
Recognized gain on change in fair value								766,666			102,800			869,466

Fair value, June 30, 2021	$	9,870,833		$	1,396,133		$	9,870,833		$	1,396,133		$	11,266,966

Recognized loss on change in fair value								(1,677,083	)		(250,069	)		(1,927,152	)

Fair value, September 30, 2021							$	8,193,750		$	1,146,064		$	9,339,814

Note ~~9 —~~ 10—Subsequent Events

In accordance with ASC Topic 855, “Subsequent Events,” which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before

condensed

financial statements are issued. The Company evaluated subsequent events that occurred after the balance sheet date up to the date the condensed financial statements were ~~available to be~~ issued and, except as described below, the Company has concluded that all such events that would require adjustment or disclosure have been recognized or disclosed.

On November 8, 2021, the Company entered into an Investment Agreement and Plan of Merger (the “Investment Agreement”) with Panera Brands, Inc., a Delaware corporation (“Panera”), and Rye Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Panera (“Merger Sub”), pursuant to which Merger Sub will merge with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Panera (the “Merger”).

Upon the terms and subject to the conditions set forth in the Investment Agreement, at the effective time of the Merger (the “Effective Time”), each issued and outstanding share of the Company’s Class A common stock and each issued and outstanding share of the Company’s Class B common stock will be converted into the right to receive a number of shares of Panera’s common stock, par value $0.01 per share (“Panera Common Stock”) at an exchange ratio of $10.00 divided by the public offering price per share in the Panera IPO (as defined below). In addition, at the Effective Time, each issued and outstanding warrant of the Company will be assumed by Panera and will relate to Panera Common Stock (each, a “Warrant”) (with the number of shares of Panera Common Stock underlying each Warrant adjusted in accordance with the terms of the Investment Agreement).

The consummation of the proposed Transactions (as defined in the Investment Agreement) is subject to the receipt of the requisite approval of the stockholders of the Company (such approval, the “HUGS stockholder approval”) and the fulfillment of certain other conditions, including the consummation of Panera’s initial public offering of Panera Common Stock (the “Panera IPO”).

Table of Contents

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to USHG Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to USHG Investments, LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance, or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward- looking statements, please refer to the Risk Factors section of the Company’s Quarterly Report on Form

10-Q

for the three months ended March 31, 2021 filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 24, 2021 and the Company’s final prospectus for its initial public offering (the “Initial Public Offering”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated on December 4, 2020 as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities (“Business Combination”). We intend to effectuate our Business Combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants (as defined below), our shares, debt, or a combination of cash, equity, and debt. We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.

Our Sponsor is USHG Investments, LLC, a Delaware limited liability company. The registration statement for the Initial Public Offering was declared effective on February 24, 2021. On March 1, 2021, we consummated the Initial Public Offering of 28,750,000 units (“Units” and, with respect to the Class A common stock included in the units being offered, the “public shares”), including 3,750,000 over-allotment Units, at $10.00 per Unit, generating gross proceeds of $287.5 million, and incurring offering costs of approximately $784,282, inclusive of approximately $15.8 million in deferred underwriting commissions.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (the “Private Placement”) of 1,333,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant to the Sponsor, generating proceeds of $2.0 million.

Table of Contents

Upon the closing of the Initial Public Offering and the Private Placement, $287.5 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering was held in a trust account (“Trust Account”) located in the United States with American Stock Transfer & Trust Company, LLC acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”) having a maturity of 180 days or less or in money market funds meeting certain conditions under

Rule 2a-7

promulgated under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.

If we are unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or March 1, 2023, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a

per-share

price, payable in cash, equal to the aggregate amount

~~Table of Contents~~

then on deposit in the Trust account including interest earned on the funds held in the Trust account and not previously released to us to pay our taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining stockholders and our board of directors, dissolve and liquidate, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

Recent Developments

Results of Operations

We have neither engaged in any operations (other than searching for a Business Combination after the Initial Public Offering) nor generated any revenues to date. We do not expect to generate any operating revenues until after the completion of our Business Combination. We expect to generate

non-operating

income in the form of interest income on cash and cash equivalents. We incur expenses as a result of being a public company (for legal, financial reporting, accounting, and auditing compliance), as well as for due diligence expenses.

For the three months ended ~~June~~September 30, 2021, we had a net ~~loss~~income of approximately ~~$1.21 million,~~$1,643,080, which consisted of approximately ~~$0.24 million~~$238,414 in formation and operating costs ~~approximately $0.1 million~~and $50,000 in franchise tax expense, ~~and approximately $0.87 million loss~~offset by an $1,927,152 gain from change in fair value of warrant liabilities ~~offset~~and by ~~and approximately $0.004 million~~$4,342 in interest income onfrom funds held in the Trust Account.

For the ~~six~~nine months ended ~~June~~September 30, 2021, we had a net income of approximately ~~$2.55 million,~~$4,194,795, which consisted of approximately ~~$0.31 million~~$549,959 in formation and operating costs, ~~approximately $0.1 million~~$150,000 in franchise tax ~~expense.~~expense and approximately ~~$0.76 million~~$757,984 in offering costs allocated to derivative warrant liabilities, offset by ~~approximately $3.7 million~~$5,642,686 gain from change in fair value of warrant liabilities and ~~approximately $0.005 million~~$10,052 in income onfrom funds held in the Trust Account.

Off-Balance

Sheet Arrangements

We did not have any

off-balance

sheet arrangements as of ~~June~~September 30, 2021.

Contractual Obligations

~~We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.~~

The underwriters are entitled to a deferred fee of $0.55 per Unit, or $15,812,500 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement.

We have entered into an Administrative Services Agreement pursuant to which the Company will pay an affiliate of the Sponsor a total of $10,000 per month for office space, secretarial and administrative services. We will make payments to the Sponsor until the earlier of the completion of the Initial Business Combination or the liquidation of the trust assets. We paid $30,000 and $80,000 for the services provided through the Administrative Services Agreement for the three and nine months ended September 30, 2021, respectively.

Critical Accounting Policies

The preparation of unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following as our critical accounting policies:

Investments Held in the Trust Account

Our portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities, or a combination thereof. The investments held in the Trust Account are classified as trading

Table of Contents

securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income from investments held in the Trust Account in the accompanying statement of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

~~Table of Contents~~

Class A Common Stock Subject to Possible Redemption

We account for our Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable shares of Class A common stock (including shares of Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, shares of Class A common stock are classified as stockholders’ equity. Our shares of Class A common stock feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of ~~June~~September 30, 2021, ~~25,619,550~~28,750,000 shares of Class A common stock subject to possible redemption were presented as temporary equity, outside of the stockholders’ equity section of the accompanying balance sheet. The Class A common stock subject to possible redemption reflected on the balance sheet as September 30, 2021 are reconciled in the following table:


Gross proceeds	$	287,500,000


Less:
Proceeds allocated to public warrants		(13,129,167	)
Class A shares offering costs at closing		(15,845,671	)
Additional offering costs incurred during the three months ended June 30, 2021		(42,160	)

Plus:
Total accretion of carrying value to redemption value		29,016,998

Class A common stock subject to possible redemption	$	287,500,000

Net Income ~~(Loss)~~ Per Share of Common Stock

We ~~apply the~~

~~two-class~~

~~method in calculating earnings per share.~~comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income ~~(loss)~~ per common share ~~basic and diluted for Class A redeemable common stock~~ is ~~calculated~~computed by dividing ~~the interest and dividend~~net income ~~earned on the Trust Account,~~ by the weighted average number of shares of ~~Class A redeemable~~ common stock outstanding ~~for~~during the period. ~~Net loss~~We have not considered the effect of the warrants sold in the Initial Public Offering and Private Placement in the calculation of diluted income per ~~common~~ share, ~~basic~~because the exercise of the warrants are contingent upon the occurrence of future events and ~~diluted for~~the inclusion of such warrants would be anti-dilutive. Accretion associated with the redeemable Class B

~~non-redeemable~~

A common stock is ~~calculated by dividing net loss less income attributable to Class A redeemable common stock, by~~excluded from earnings per share as the ~~weighted average number of shares of Class B~~

~~non-redeemable~~redemption value approximates fair value.

~~common stock outstanding for the period presented.~~

Warrant Liability

The Company accounts for the warrants in accordance with the guidance contained in ASC

815-40-15-7D

and 7F under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to

re-measurement

at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The ~~fair value of the Public Warrants has been estimated using a Monte Carlo simulation model. The~~ Private Placement Warrants are valued using a Modified Black Scholes Option Pricing Model.

Recent accounting standards

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)

2020-06,

Debt — Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic

815-40) (“

(“ASU

2020-06”)

to simplify accounting for certain financial instruments. ASU

2020-06

amends the diluted earnings per share guidance, including the requirement to use the

if-converted

method for all convertible instruments. ASU

2020-06

is effective January 1, ~~2022~~2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. Management is currently evaluating the new guidance but does not expect the adoption of this guidance to have a material impact on the Company’s financial statements.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As of ~~June~~September 30, 2021, we were not subject to any market or interest rate risk. Following the consummation of the Initial Public Offering, the net proceeds of the Initial Public Offering, including amounts in the Trust Account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 180 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended ~~June~~September 30, 2021, as such term is defined in

Rules 13a-15(e)

and

15d-15(e)

under the Exchange Act. Based ~~on this~~upon their evaluation, our management, including our principal executive officer and principal financial and accounting officer, ~~have~~ concluded that ~~during the period covered by this report,~~ our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective as of September 30, 2021, due ~~solely~~ to a failure to correctly apply the nuances of the complex accounting standards that apply to our financial statements, including with respect to certain complex features of the Company’s Class A common stock, which resulted in the material weakness in our internal control over financial reporting described below in “Changes in Internal Control ~~over~~Over Financial Reporting.” In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report ~~on Form 10-Q~~ present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met.

19Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

~~Table of Contents~~

Changes in Internal Control over Financial Reporting

~~There were no changes in our internal control over financial reporting (as such term is defined in Rules~~

~~13a-15(f)~~

~~and~~

~~15d-15(f)~~

In light of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. However, as described above, management did implement changes in internal control over financial reporting during second quarter of 2021 designed to remediate the presentation of the Company’s warrants as equity instead of liability.

Our internal control over financial reporting did not result in the proper accounting classification of certain of the warrants we issued in March 2021 which, due to its impact on our financial statements, we determined to be athis material ~~weakness. This mistake in classification was brought to our attention only when~~weakness, the SEC issued a Staff Statement on Accounting and Reporting Considerations for warrants Issued by Special Purpose Acquisition Companies (“SPACs”) dated April 12, 2021 (the “SEC Statement”). The SEC Statement addresses certain accounting and reporting considerations related to warrants of a kind similar to those we issued at the time of our Initial Public Offering in March 2021.

The Chief Executive Officer and Chief Financial Officer performed additional accounting and financial analyses and other post-closing procedures including consulting with subject matter experts related to the accounting for the Public Warrants and Private Placement Warrants. The Company’s management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. ~~While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions,~~Specifically, we have expanded and ~~will continue~~improved our review process for complex securities and related accounting standards, including enhancing access to ~~improve these processes~~accounting literature and improving identification of third-party professionals with whom to ~~ensure that the nuances of~~consult regarding complex accounting applications. Other than as described herein, there were no changes in our internal control over financial reporting (as such ~~transactions are effectively evaluated~~term is defined in ~~the context~~Rules 13a-15(f) and 15d-15(f) of the ~~increasingly complex accounting standards.~~Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our final prospectus filed with the SEC on February 25, 2021 and our most recent quarterly report on Form

10-Q

for the three months ended ~~March 31,~~June 30, 2021 filed with the SEC on ~~May 24,~~August 16, 2021. As of the date of this Report, there have been no material changes to the risk factors disclosed in our final prospectus or our quarterly report on Form

10-Q

for the three months ended ~~March 31,~~June 30, 2021 filed with the SEC on ~~May 24, 2021 filed with the SEC.~~August 16, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

On March 1, 2021, we consummated the Initial Public Offering of 28,750,000 Units, including 3,750,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional Units to cover over-allotments. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $287,500,000. Goldman Sachs & Co. LLC and Piper Sandler & Co acted as joint book-running managers for the Initial Public Offering. The securities in the offering were registered under the Securities Act on a registration statement on Form

S-1

(No.

333-252802).

The Securities and Exchange Commission declared the registration statement effective on February 24, 2021.

Simultaneously with the consummation of the Initial Public Offering and the full exercise of the over-allotment option, we consummated the private placement of an aggregate of 1,333,333 warrants at a price of $1.50 per Private Placement Warrant, generating total proceeds of $2,000,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

The Private Placement Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants are not transferable, assignable, or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.

Of the gross proceeds received from the Initial Public Offering, the full exercise of the over-allotment option and the sale of the Private Placement Warrants, $287,500,000 was placed in the Trust Account.

We incurred approximately ~~$791,156~~$833,315 for offering costs related to the Initial Public Offering. In addition, the underwriters agreed to defer $15,812,500 in underwriting discounts.

For a description of the use of the proceeds generated in the Initial Public Offering, see Part I, Item 2 of this report.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None.

2021

Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form

10-Q.


No.		Description of Exhibit

31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

101.INS*		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.SCH*		Inline XBRL Taxonomy Extension Schema Document.

101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document.

101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

*	Filed herewith.

**	Furnished.

2122

Table of Contents

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	USHG ACQUISITION CORP.

Date: ~~August~~November 16, 2021	By:	/s/ Adam D. Sokoloff
	Name:	Adam D. Sokoloff
	Title:	Chief Executive Officer and Director (Principal Executive Officer)

Date: ~~August~~November 16, 2021	By:	/s/ Tiffany F. Daniele
	Name:	Tiffany F. Daniele
	Title:	Chief Financial Officer (Principal Accounting and Financial Officer)


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant	HUGSU	New York Stock Exchange
Class A common stock, par value $0.0001 per share	HUGS	New York Stock Exchange
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share	HUGSW	New York Stock Exchange


Large accelerated filer	☐	Accelerated filer	☐

Non-accelerated filer ~~filer~~	☒	Smaller reporting company	☒


		Emerging growth company	☒


	Three Months Ended September 30, 2021			Nine Months Ended September 30, 2021
Formation and operating costs	$	238,414		$	549,959
Franchise tax expense		50,000			150,000

Loss from operations		(288,414	)		(699,959	)
Other Income (Expense):
Change in fair value of warrant liabilities		1,927,152			5,642,686
Offering costs allocated to derivative warrant liabilities		0			(757,984	)
Interest on marketable securities		4,342			10,052

Net Income	$	1,643,080		$	4,194,795

Weighted average shares outstanding of Class A common stock, basic and diluted		28,750,000			22,536,630

Basic and diluted net income per share of Class A common stock	$	0.05		$	0.14

Weighted average shares outstanding of Class B common stock, basic and diluted		6,934,500			6,934,500

Basic and diluted net income per share of Class B common stock	$	0.05		$	0.14


		Page No.
PART I. FINANCIAL INFORMATION			2

Item 1.	Financial Statements		2

	Condensed Balance Sheets as of ~~June~~September 30, 2021 (Unaudited) and December 31,2020		2

	Unaudited Condensed Statements of Operations for the Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2021		3

	Unaudited Condensed Statement of Changes in Stockholders’ Equity (Deficit) for the Three and ~~Six~~Nine Months Ended ~~June~~September 30, 2021		4

	Unaudited Condensed Statement of Cash Flows for the ~~Six~~Nine Months Ended ~~June~~September 30, 2021		5

	Notes to Unaudited Condensed Financial Statements		6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		17

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		19

Item 4.	Controls and Procedures		1920

PART II. OTHER INFORMATION			2021

Item 1.	Legal Proceedings		2021

Item 1A.	Risk Factors		2021

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		2021

Item 3.	Defaults Upon Senior Securities		2021

Item 4.	Mine Safety Disclosures		2021

Item 5.	Other Information		2021

Item 6.	Exhibits		2122

SIGNATURES


	June 30, 2021		December 31, 2020
	(Unaudited)
ASSETS
Cash	$	770,670	$	24,120
Deferred offering costs associated with proposed public offering		—		255,000
Prepaid expenses		479,586		—

Total current assets		1,250,256		279,120
Marketable securities held in trust account		287,505,711		—
Other assets		301,557		—

Total assets	$	289,057,524	$	279,120

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	51,231	$	—
Franchise tax payable		100,000		—
Due to related party		1,567		—
Accrued offering and formation costs		16,050		265,000

Total current liabilities		168,848		265,000
Warrant liabilities		11,266,966		—
Deferred underwriting compensation		15,812,500		—
Deferred legal fees		613,708		—

Total liabilities		27,862,022		265,000

Commitments and Contingencies (Note 5)		0		0
Common stock subject to possible redemption, 25,619,550 shares at redemption value		256,195,500		—
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; NaN issued and outstanding		0—		0—
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 3,130,450 shares and -0- shares issued and outstanding (excluding 25,619,550 -0- shares subject to possible redemption), as of June 30, 2021 and December 31, 2020, respectively		313		—
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,934,500 shares issued and outstanding, as of June 30, 2021 and December 31, 2020		693		693
Additional paid-in capital		2,457,282		23,427
Retained earnings (accumulated deficit)		2,541,714		(10,000	)

Total stockholders’ equity		5,000,002		14,120

Total Liabilities and Stockholders’ Equity	$	289,057,524	$	279,120


	September 30, 2021			December 31, 2020
	(Unaudited)
ASSETS
Cash	$	631,308		$	24,120
Deferred offering costs associated with proposed public offering		—			255,000
Prepaid expenses		469,504			—

Total current assets		1,100,812			279,120
Marketable securities held in trust account		287,510,052			—
Other assets		187,387			—

Total assets	$	288,798,251		$	279,120

LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	19,650		$	—
Franchise tax payable		150,000			—
Accrued offering and formation costs		23,995			265,000

Total current liabilities		193,645			265,000
Warrant liabilities		9,339,814			—
Deferred underwriting compensation		15,812,500			—
Deferred legal fees		613,708			—

Total liabilities		25,959,667			265,000


Commitments and Contingencies		0			0
Common stock subject to possible redemption, 28,750,000 shares at $10.00 redemption value		287,500,000			—
Stockholders’ Equity ( Deficit ) :
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 0ne issued or outstanding		0—			0—
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 0ne issued or outstanding (excluding 28,750,000 and 0 shares subject to possible redemption), as of September 30, 2021 and December 31, 2020, respectively		0			—
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,934,500 shares issued and outstanding		693			693
Additional paid-in capital		0			23,427
Retained earnings (accumulated deficit)		(24,662,109	)		(10,000	)

Total stockholders’ (deficit) equity		(24,661,416	)		14,120

Total Liabilities and Stockholders’ (Deficit) Equity	$	288,798,251		$	279,120


	Three Months Ended June 30, 2021			Six Months Ended June 30, 2021
Formation and operating costs	$	249,424		$	311,547
Franchise tax expense		100,000			100,000

Loss from operations		(349,424	)		(411,547	)
Other Income (Expense):
Change in fair value of warrant liabilities		(869,466	)		3,715,534
Offering costs allocated to derivative warrant liabilities		0			(757,984	)
Interest on marketable securities		4,295			5,711

Net Income (Loss)		(1,214,595	)		2,551,714

Weighted average shares outstanding of Class A common stock, basic and diluted		28,750,000			28,750,000

Basic and diluted net income per share of Class A common stock	$	0.00		$	0.00

Weighted average shares outstanding of Class B common stock, basic and diluted		6,934,500			6,934,500

Basic and diluted net loss per share of Class B common stock	$	(0.18	)	$	0.37


	Common Stock				Additional Paid-In Capital			Accumulated Deficit			Total Stockholders’ Equity (Deficit)
	Class B
	Shares		Amount
Balance as of January 1, 2021		6,934,500	$	693	$	23,427		$	(10,000	)	$	14,120
Excess cash received over fair value of Private Placement Warrants		—		—		146,667			—			146,667
Accretion of Class A Common Stock to redemption value		—		—		(170,094	)		(28,804,744	)		(28,974,838	)
Net income		—		—		—			3,766,309			3,766,309

Balance as of March 31, 2021 (as restated)		6,934,500	$	693	$	0		$	(25,048,435	)	$	(25,047,742	)
Accretion of Class A Common Stock to redemption value for additional offering cost s incurred in the period		—		—		—			(42,160	)		(42,160	)
Net loss		—		—		—			(1,214,594	)		(1,214,594	)

Balance as of June 30, 2021 (as restated)		6,934,500	$	693	$	—		$	(26,305,189	)	$	(26,304,496	)
Net income		—		—		—			1,643,080			1,643,080

Balance as of September 30, 2021		6,934,500	$	693	$	—		$	(24,662,109	)	$	(24,661,416	)


	Common Stock										Additional Paid- In Capital			Retained Earnings			Total
	Class A						Class B							Retained Earnings			Total
	Shares			Amount			Shares		Amount					(Accumulated Deficit)			Stockholders’ Equity
Balance as of January 1, 2021		—		$	—			6,934,500	$	693	$	23,427		$	(10,000	)	$	14,120
Sale of Units in initial public offering, less fair value of public warrants		28,750,000			2,875			—		—		274,367,958			—			274,370,833
Offering costs		—			—			—		—		(15,845,672	)		—			(15,845,672	)
Excess of cash received over fair value of warrants sold to Sponsor		—			—			—		—		146,667			—			146,667
Change in Class A common stock subject to possible redemption		(25,745,225	)		(2,575	)		—		—		(257,449,675	)		—			(257,452,250	)
Net income		—			—			—		—		—			3,766,309			3,766,309

Balance as of March 31, 2021(unaudited)		3,004,775		$	300			6,934,500	$	693	$	1,242,705		$	3,756,309		$	5,000,007

Offering costs related to Initial Public Offering		—			—			—		—		(42,160	)		—			(42,160	)
Change in Class A common stock subject to possible redemption		125,675			13			—		—		1,256,737			—			1,256,750
Net loss		—			—			—		—		—			(1,214,595	)		(1,214,595	)

Balance as of June 30, 2021 (unaudited)		3,130,450		$	313			6,934,500	$	693	$	2,457,282		$	2,541,714		$	5,000,002


	For the six months ended June 30, 2021
Cash Flows from Operating Activities
Net income	$	2,551,714
Adjustments to reconcile net income to net cash used in operating activities
Amortization of prepaid insurance		174,769
Change in fair value of warrant liabilities		(3,715,534	)
Offering costs allocated to derivative warrant liabilities		757,984
Interest earned on marketable securities in Trust Account		(5,711	)
Formation and operating expenses funded by Sponsor		1,567
Changes in operating assets and liabilities
Prepaid expenses		(541,426	)
Other assets		(414,486	)
Accounts payable		31,231
Franchise tax payable		100,000
Accrued expenses		6,050

Net cash used by operating activities		(1,053,842	)

Cash Flows from Investing Activities
Cash deposited in Trust Account		(287,500,000	)

Net cash used in investing activities		(287,500,000	)

Cash Flows from Financing Activities
Proceeds from issuance of Class A common stock and warrants		289,500,000
Proceeds from note payable and advances from related party		334,000
Repayment of note payable and advances from related party		(334,000	)
Payment of offering costs		(199,608	)

Net cash provided by financing activities		289,300,392

Net increase in cash		746,550
Cash—beginning of period		24,120

Cash—end of period	$	770,670

Supplemental disclosure of noncash investing and financing activities:
Change in value of Class A common stock subject to possible redemption	$	1,272,990

Warrant liabilities in connection with initial public offering and private placement	$	14,982,500

Deferred offering costs included in accounts payable	$	20,000


Deferred legal fees	$	613,708

Deferred underwriting compensation	$	15,812,500

~~001-40109~~

(State or other jurisdiction of
~~incorporation)~~

~~(Commission~~
~~File Number)~~
incorporation)

(Commission
File Number)

(I.R.S. Employer
Identification No.)

853 Broadway, 17th Floor
New York, New York

(Address of Principal Executive Offices)

(Zip Code)